Journal Mobile Options
Table of Contents
Vol. 228, No. 1, 2012
Issue release date: June 2012
Ophthalmologica 2012;228:13–18
(DOI:10.1159/000337234)

Spectral-Domain Optical Coherence Tomography in Uveitic Macular Edema: Morphological Features and Prognostic Factors

Iannetti L. · Spinucci G. · Abbouda A. · De Geronimo D. · Tortorella P. · Accorinti M.
Department of Ophthalmology, Sapienza University of Rome, Rome, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Aim: To assess the morphological characteristics of uveitic macular edema studied with Spectralis optical coherence tomography (OCT) and to investigate the correlation between the tomographic features and visual acuity. Methods: 71 eyes of 55 patients underwent examination with Spectralis OCT (Heidelberg Engineering, Germany). Data was correlated with logMAR best-corrected visual acuity (BCVA). Results: Two morphological patterns were observed: cystoid macular edema (CME) in 69% and diffuse macular edema in 31% of eyes. BCVA was 0.2 in CME, 0.1 in diffuse edema (p = 0.008). Foveal thickness was 413.4 ± 212 µm in CME, 311.27 ± 53 µm in diffuse edema (p = 0.03). BVCA was 0.3 in eyes with serous retinal detachment (SRD), 0.2 in eyes without SRD (p = 0.02). BCVA was 0.4 in eyes with inner segment/outer segment (IS/OS) disruption, 0.1 in eyes with integrity of the IS/OS junction (p = 0.01). Conclusions: BCVA is negatively correlated with cystoid pattern, foveal thickening and SRD. Disruption of the IS/OS junction is associated with poor vision in uveitic macular edema.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Puliafito CA, Hee M, Lin C, et al: Imaging of macular disease with optical coherence tomography. Ophthalmology 1995;102:217–229.
  2. Huang D, Swanson E, Lin CP, et al: Optical coherence tomography. Science 1991;254:1178–1181.
  3. Wolf S, Wolf-Schnurrbusch U: Spectral-domain optical coherence tomography use in macular diseases: a review. Ophthalmologica 2010;224:333–340.
  4. Pivetti-Pezzi P, Accorinti M, La Cava M, et al: Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica 1996;210:234–238.
  5. Markomichelakis N, Halkiadakis I, Pantelia E, Georgalas E, Anthi K, Theodossiadis P, Moschos M, Theodossiadis G, Kouvatseas G: Course of macular edema in uveitis under medical treatment. Ocul Immunol Inflamm 2007;15:71–79.

    External Resources

  6. Pivetti-Pezzi P, Accorinti M, La Cava M, Colabelli Gisoldi RA, Abdulaziz MA: Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica 1996;210:234–238.
  7. Thurau SR: Cystoid macular edema in uveitis. Ophthalmologe 2005;102:485–490.
  8. Antcliff RJ, Stanford MR, Chauhan DS, et al: Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology 2000;103:1889–1898.
  9. Markomichelakis N, Halkiadakis I, Pantelia E, et al: Patterns of macular edema in patients with uveitis. Qualitative and quantitative assessment using optical coherence tomography. Ophthalmology 2004;111:946–952.
  10. Iannetti L, Accorinti M, Liverani M, Caggiano C, Abdulaziz R, Pivetti-Pezzi P: Optical coherence tomography for classification and clinical evaluation of macular edema in patients with uveitis. Ocul Immunol Inflamm 2008;16:155–160.

    External Resources

  11. Tran TH, de Smet MD, Bodaghi B, et al: Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol 2008;92:922–927.
  12. Roesel M, Henschel A, Heinz C, et al: Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema. Graefes Arch Clin Exp Ophthalmol 2009;247:1685–1689.
  13. Bloch-Michel E, Nussenblatt RB: International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987;103:234–235.
  14. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group: Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509–516.

    External Resources

  15. Otani T, Kishi S, Maruyama Y: Pattern of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999;127:688–693.
  16. Massin P, Allouch C, Haouchine B, et al: Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery. Am J Ophthalmol 2000;130:732–739.
  17. Yanoff M, Fine BS, Brucker AJ, et al: Pathology of human cystoid macular edema. Surv Ophthalmol 1984;28:505–511.
  18. Malinowski SM, Pulido JS, Folk JC: Long term visual outcome and complications associated with pars planitis. Ophthalmolgy 1993;100:818–825.
  19. Maheshwary AS, Oster SF, Yuson RM, Cheng L, Mojana F, Freeman WR: The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol 2010;150:63–67.
  20. Oster SF, Mojana F, Brar M, Yuson RM, Cheng L, Freeman WR: Disruption of the photoreceptor inner segment/outer segment layer on spectral domain-optical coherence tomography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina 2010;30:713–718.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50